{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:53:27Z","timestamp":1792428807560,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T00:00:00Z","timestamp":1398729600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2377-14-93","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T15:02:53Z","timestamp":1398783773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status"],"prefix":"10.1186","volume":"14","author":[{"given":"Sung-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,29]]},"reference":[{"issue":"2","key":"1018_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011, 69 (2): 292-302. 10.1002\/ana.22366.","journal-title":"Ann Neurol"},{"issue":"10","key":"1018_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006, 66 (10): 1485-1489. 10.1212\/01.wnl.0000216139.44259.74.","journal-title":"Neurology"},{"issue":"9","key":"1018_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6 (9): 805-815. 10.1016\/S1474-4422(07)70216-8.","journal-title":"Lancet Neurol"},{"issue":"10","key":"1018_CR4","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1001\/archneur.64.10.1426","volume":"64","author":"J de Seze","year":"2007","unstructured":"de Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, Wiertlewski S, Pittion S, Laplaud D, Le Page E: Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol. 2007, 64 (10): 1426-10.1001\/archneur.64.10.1426.","journal-title":"Arch Neurol"},{"issue":"4","key":"1018_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/WNL.60.4.730","volume":"60","author":"Transverse Myelitis Consortium Working Group","year":"2003","unstructured":"Transverse Myelitis Consortium Working Group: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2003, 60 (4): 730-10.1212\/WNL.60.4.730.","journal-title":"Neurology"},{"key":"1018_CR6","first-page":"82","volume-title":"International MS journal\/MS Forum: 2009","author":"P Shams","year":"2009","unstructured":"Shams P, Plant G: Optic neuritis: a review. International MS journal\/MS Forum: 2009. 2009, 82-"},{"issue":"9451","key":"1018_CR7","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364 (9451): 2106-2112. 10.1016\/S0140-6736(04)17551-X.","journal-title":"Lancet"},{"issue":"3","key":"1018_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3988\/jcn.2011.7.3.115","volume":"7","author":"W Kim","year":"2011","unstructured":"Kim W, Kim SH, Kim HJ: New insights into neuromyelitis optica. J Clin Neurol. 2011, 7 (3): 115-127. 10.3988\/jcn.2011.7.3.115.","journal-title":"J Clin Neurol"},{"issue":"12","key":"1018_CR9","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1007\/s00415-011-6086-x","volume":"258","author":"SM Kim","year":"2011","unstructured":"Kim SM, Waters P, Vincent A, Go MJ, Park KS, Sung JJ, Lee KW: Cerebrospinal fluid\/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica. J Neurol. 2011, 258 (12): 2176-2180. 10.1007\/s00415-011-6086-x.","journal-title":"J Neurol"},{"issue":"9","key":"1018_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1212\/WNL.0b013e31822c61b1","volume":"77","author":"S Siritho","year":"2011","unstructured":"Siritho S, Nakashima I, Takahashi T, Fujihara K, Prayoonwiwat N: AQP4 antibody-positive Thai cases: clinical features and diagnostic problems. Neurology. 2011, 77 (9): 827-834. 10.1212\/WNL.0b013e31822c61b1.","journal-title":"Neurology"},{"issue":"2","key":"1018_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","volume":"2","author":"J Kira","year":"2003","unstructured":"Kira J: Multiple sclerosis in the Japanese population. Lancet Neurol. 2003, 2 (2): 117-127. 10.1016\/S1474-4422(03)00308-9.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1018_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1352458508098372","volume":"15","author":"M Osoegawa","year":"2009","unstructured":"Osoegawa M, Kira J, Fukazawa T, Fujihara K, Kikuchi S, Matsui M, Kohriyama T, Sobue G, Yamamura T, Itoyama Y, Saida T, Sakata K, Ochi H, Matsuoka T, Research Committee of Neuroimmunological Diseases: Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler. 2009, 15 (2): 159-173.","journal-title":"Mult Scler"},{"issue":"11","key":"1018_CR13","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","volume":"256","author":"E Bizzoco","year":"2009","unstructured":"Bizzoco E, Lolli F, Repice A, Hakiki B, Falcini M, Barilaro A, Taiuti R, Siracusa G, Amato M, Biagioli T: Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol. 2009, 256 (11): 1891-10.1007\/s00415-009-5171-x.","journal-title":"J Neurol"},{"issue":"3","key":"1018_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1352458513495580","volume":"20","author":"RM Papais-Alvarenga","year":"2014","unstructured":"Papais-Alvarenga RM, Vasconcelos CC, Alves-Leon SV, Batista E, Santos CM, Camargo SM, Godoy M, Lacativa MC, Lorenti M, Damasceno B: The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project. Mult Scler. 2014, 20 (3): 374-381. 10.1177\/1352458513495580.","journal-title":"Mult Scler"},{"issue":"21","key":"1018_CR15","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1212\/WNL.0b013e3181feb26f","volume":"75","author":"M Tintore","year":"2010","unstructured":"Tintore M, Rovira A, Arrambide G, Mitjana R, Rio J, Auger C, Nos C, Edo M, Castillo J, Horga A: Brainstem lesions in clinically isolated syndromes. Neurology. 2010, 75 (21): 1933-1938. 10.1212\/WNL.0b013e3181feb26f.","journal-title":"Neurology"},{"issue":"5","key":"1018_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00234-007-0216-2","volume":"49","author":"AR Canellas","year":"2007","unstructured":"Canellas AR, Gols AR, Izquierdo JR, Subirana MT, Gairin XM: Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology. 2007, 49 (5): 393-409. 10.1007\/s00234-007-0216-2.","journal-title":"Neuroradiology"},{"key":"1018_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/brain\/121.3.495","volume":"121","author":"J O'Riordan","year":"1998","unstructured":"O'Riordan J, Thompson A, Kingsley D, MacManus D, Kendall B, Rudge P, McDonald W, Miller D: The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain. 1998, 121: 495-10.1093\/brain\/121.3.495.","journal-title":"Brain"},{"issue":"4","key":"1018_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/WNL.59.4.499","volume":"59","author":"TMCW Group","year":"2002","unstructured":"Group TMCW: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002, 59 (4): 499-505.","journal-title":"Neurology"},{"issue":"3","key":"1018_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA: Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006, 59 (3): 566-569. 10.1002\/ana.20770.","journal-title":"Ann Neurol"},{"issue":"24","key":"1018_CR20","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/WNL.0b013e31823dc535","volume":"77","author":"T Scott","year":"2011","unstructured":"Scott T, Frohman E, De Seze J, Gronseth G, Weinshenker B: Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011, 77 (24): 2128-10.1212\/WNL.0b013e31823dc535.","journal-title":"Neurology"},{"issue":"22","key":"1018_CR21","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Magnone MC, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F: A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009, 73 (22): 1914-1922. 10.1212\/WNL.0b013e3181c47cc2.","journal-title":"Neurology"},{"issue":"9","key":"1018_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ: Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012, 78 (9): 665-671. 10.1212\/WNL.0b013e318248dec1. discussion 669","journal-title":"Neurology"},{"issue":"3","key":"1018_CR23","first-page":"99","volume":"15","author":"P Waters","year":"2008","unstructured":"Waters P, Vincent A: Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J. 2008, 15 (3): 99-105.","journal-title":"Int MS J"},{"issue":"7","key":"1018_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA: Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006, 63 (7): 964-968. 10.1001\/archneur.63.7.964.","journal-title":"Arch Neurol"},{"issue":"9","key":"1018_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/WNL.0b013e31822b012a","volume":"77","author":"BG Weinshenker","year":"2011","unstructured":"Weinshenker BG, Carroll WM: Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?. Neurology. 2011, 77 (9): 812-813. 10.1212\/WNL.0b013e31822b012a.","journal-title":"Neurology"},{"issue":"18","key":"1018_CR26","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","volume":"76","author":"N Asgari","year":"2011","unstructured":"Asgari N, Lillevang ST, Skejoe HP, Falah M, Stenager E, Kyvik KO: A population-based study of neuromyelitis optica in Caucasians. Neurology. 2011, 76 (18): 1589-1595. 10.1212\/WNL.0b013e3182190f74.","journal-title":"Neurology"},{"issue":"16","key":"1018_CR27","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1212\/WNL.0b013e3181f88191","volume":"75","author":"NH Kim","year":"2010","unstructured":"Kim NH, Kim HJ, Cheong HK, Kim BJ, Lee KH, Kim EH, Kim EA, Kim S, Park MS, Yoon WT: Prevalence of multiple sclerosis in Korea. Neurology. 2010, 75 (16): 1432-1438. 10.1212\/WNL.0b013e3181f88191.","journal-title":"Neurology"},{"issue":"19","key":"1018_CR28","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1212\/WNL.0b013e3181fc2823","volume":"75","author":"P Huppke","year":"2010","unstructured":"Huppke P, Bluthner M, Bauer O, Stark W, Reinhardt K, Huppke B, Gartner J: Neuromyelitis optica and NMO-IgG in European pediatric patients. Neurology. 2010, 75 (19): 1740-1744. 10.1212\/WNL.0b013e3181fc2823.","journal-title":"Neurology"},{"issue":"15","key":"1018_CR29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1212\/WNL.0b013e31824f8069","volume":"78","author":"SH Kim","year":"2012","unstructured":"Kim SH, Kim W, Li XF, Jung IJ, Kim HJ: Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology. 2012, 78 (15): 1179-1185. 10.1212\/WNL.0b013e31824f8069.","journal-title":"Neurology"},{"issue":"8","key":"1018_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1177\/1352458511403794","volume":"17","author":"C Ahlgren","year":"2011","unstructured":"Ahlgren C, Od\u00e9n A, Lycke J: High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler. 2011, 17 (8): 901-10.1177\/1352458511403794.","journal-title":"Mult Scler"},{"issue":"14","key":"1018_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","volume":"81","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, McKeon A, Costanzi C, Iorio R, Weinshenker BG: Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013, 81 (14): 1197-1204. 10.1212\/WNL.0b013e3182a6cb5c.","journal-title":"Neurology"},{"issue":"1-2","key":"1018_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jneuroim.2012.07.007","volume":"15;251","author":"S Sato","year":"2012","unstructured":"Sato S, Isobe N, Yoshimura S, Kanamori Y, Masaki K, Matsushita T, Kira J: HLA-DPB1 0201 is associated with susceptibility to atopic myelitis in Japanese. J Neuroimmunol. 2012, 15;251 (1-2): 110-113.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"1018_CR33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P, Leite M, Devenney E, Craig J, Palace J, Vincent A: Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology. 2012, 79 (12): 1273-10.1212\/WNL.0b013e31826aac4e.","journal-title":"Neurology"},{"issue":"8","key":"1018_CR34","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1177\/1352458512472748","volume":"19","author":"SM Kim","year":"2013","unstructured":"Kim SM, Waters P, Woodhall M, Kim JY, Kim JE, Yang JW, Kim JS, Sung JJ, Park KS, Lee KW: Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders. Mult Scler. 2013, 19 (8): 1060-1067. 10.1177\/1352458512472748.","journal-title":"Mult Scler"},{"issue":"24","key":"1018_CR35","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1212\/WNL.0b013e318296ea08","volume":"80","author":"D Sato","year":"2013","unstructured":"Sato D, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nishiyama S, Suzuki C, Takai Y, Fujihara K: Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology. 2013, 80 (24): 2210-10.1212\/WNL.0b013e318296ea08.","journal-title":"Neurology"},{"issue":"24","key":"1018_CR36","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1212\/WNL.0b013e318296ea08","volume":"11;80","author":"D Sato","year":"2013","unstructured":"Sato D, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nishiyama S, Suzuki C, Takai Y, Fujihara K: Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology. 2013, 11;80 (24): 2210-2216.","journal-title":"Neurology"},{"issue":"9","key":"1018_CR37","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1177\/1352458511404917","volume":"17","author":"W Kim","year":"2011","unstructured":"Kim W, Kim SH, Lee SH, Li XF, Kim HJ: Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler. 2011, 17 (9): 1107-1112. 10.1177\/1352458511404917.","journal-title":"Mult Scler"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-14-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-14-93\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-14-93","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-14-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:50:02Z","timestamp":1630554602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-14-93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,29]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-14-93","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,29]]},"assertion":[{"value":"9 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"93"}}